Short term relapse risk after switching from natalizumab to ocrelizumab or cladribine - an international cohort study

Treffts, Johanna and Van Kesteren, Yan and Thiel, Sandra and Stahmann, Alexander and Magyari, Melinda and Berthele, Achim and Giglhuber, Katrin and Bittner, Stefan and Ellwardt, Erik and Angstwurm, Klemens and Tackenberg, Björn and Jurs, Jan and Viehover, Andrea and Klotz, Luisa and Theis, Lena and Gold, Ralf and Ellenberger, David and Hellwig, Kerstin (2021) Short term relapse risk after switching from natalizumab to ocrelizumab or cladribine - an international cohort study. In: The 73rd AAN Annual Meeting, April 17 - 22, 2021, Virtual.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Petra Gürster
Date Deposited: 17 Jan 2023 11:08
Last Modified: 17 Jan 2023 11:08
URI: https://pred.uni-regensburg.de/id/eprint/47309

Actions (login required)

View Item View Item